Feb 13, 2026
Presentation of 2025 Year-End Report
Nov 13, 2025
BioStock | Life Science Summit 2025
Nov 10, 2025
Capital Markets Day 2025
Nov 5, 2025
Presentation of Q3 2025 Interim Report
Sep 23, 2025
Redeye Theme Event Tools and Supplies in Life Science 2025
Aug 20, 2025
Presentation of Q2 2025 Interim Report
May 15, 2025
Redeye CEO interview Q1 2025
May 14, 2025
Presentation of Q1 2025 Report
May 14, 2025
Presentation of Q1 2025 Report
May 14, 2025
Presentation of Q1 2025 Report
Feb 13, 2025 at 12.00
Presentation of 2024 Year-End Report
Nov 29, 2024
Västra Hamnen möter SenzaGen (in Swedish)
Nov 21, 2024
BioStock Life Science Summit
Nov 11, 2024
Redeye: CEO interview Q3
Nov 8, 2024
Penser Access by Carnegie: VD-intervju – Stark tillväxt i Q3 (SWE)
October 4, 2024
Penserpodden by Carnegie: Avsnitt 305 om potentialen i SenzaGen
VD Peter Nählstedt förklarar bolagets produkt, position och potential.
Listen to pod (in Swedish)
August 22, 2024
Presentation of interim report January-June 2024
June 5, 2024
Carnegie Healthcare Webinar
May 17, 2024
Redeye CEO interview Q1 2024 report
May 15, 2024
Presentation of interim report January-March 2024
Breakeven in Q1 2024
April 25, 2024
Aktiespararna Lomma/Kävlinge
April 24, 2024
Redeye Theme: Medtech
Mar 14, 2024
Penser by Carnegies bolagsdag in Malmö
Feb 20, 2024
Interview with SenzaGen (SWE) – Carnegie Investment Bank:
Starkt avslut på 2023 med positiva signaler för 2024
Feb 19, 2024
Redeye interview with CEO Peter Nählstedt
Feb 14, 2024
Presentation of SenzaGen’s year-end report 2023
Archive
Dec 7, 2023
Redeye Investor Forum Online
Nov 23, 2023
Penser Bolagsdag
Oct 26, 2023
BioStock Life Science Summit
Sep 7, 2023
Penser HealthCare
Aug 24, 2023
Penser Bolagsdag
May 25, 2023
Penser Market Day
May 11, 2023
Penser: Interview with SenzaGen’s CEO (in Swedish)
May 10, 2023
Redeye Medtech Event
Dec 1, 2022
Penser Health Day
Nov 24, 2022
Redeye Life Science Day
Oct 26, 2022
Vator Life Science Summit
Sep 1, 2022
Redeye Initiate
Aug 18, 2022
Webcast: 2022 Half Year Report presentation
July 5, 2022
Webcast: GARDskin approved by OECD
May 11, 2022, Stockholm
Redeye Theme: Medtech & Diagnostics
Mar 23, 2022, Zürich
Swiss Nordic Bio
Feb 11, 2022
Conference Call: SenzaGen’s 2021 Year-End Report
2021
Dec 16, 2021
Redeye Investor Forum Online
>
Dec 2, 2021
Västra Hamnen Investerardag
October 28, 2021
Investor Presentation (pdf)
Oct 21, 2021 @ 11.00
The BioStock Life Science Summit
Oct 7, 2021
Vator Healthcare Innovation Summit
Oct 5, 2021
Capital Markets Day
Aug 19, 2021
Conference Call: SenzaGen’s 2021 Half-Year Report
July 29, 2021
Webcast: Positive scientific ESAC opinion on GARDskin
– paving the way for OECD validation and opens new commercial opportunities
May 26, 2021
CEO presentation at BioStock Life Science Spring Summit
May 5, 2021
CEO presentation at SenzaGen’s AGM 2021
March 4, 2021
BioStock Studio: SenzaGen is aiming to increase market activity in 2021
Feb 18, 2021 @ 9:30
Conference Call: SenzaGen’s 2020 Year-End report
Feb 10, 2021
Swiss Nordic Bio
2020
Nov 26, 2020
Redeye Life Science Day
Nov 17, 2020
BioStock Life Science Summit
Conference call: Half-Year Report 2020
2020 Annual General Meeting – CEO presentation
Conference call: Year-End Report 2019.
2019
December
4 december | Göteborg, Vator Securities
3 december | Stockholm, Biostock Live
3 december | Stockholm, Vator Securities
November
28 november | Stockholm, Vator Securities
27 november | Stockholm, Unicorn Summit, Vator Securities
27 november | Stockholm, Småbolagsjakten Live, Laika
25 november | Stockholm, Stora Aktiedagen, Aktiespararna
22 november | Malmö, Vator Securities
September
Telefonkonferensl | 19 september, 2019
VD Axel Sjöblad kommenterar den nya kommersiella organisationen och det nya finansiella målet.
Mars
Vator Securities Unicorn Summit | Stockholm | March 21, 2019 (in English)
